Sign in
4

Changes in Ownership

Janux Therapeutics, Inc. Filed Acc 0001415889-24-019903

Director acquired 7,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hernday Natasha · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2024-07-19 Grant or award : show line 1 in the form +5,000 5,000 D
2024-07-19 Grant or award : show line 2 in the form +2,500 7,500 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-07-19 Grant or award : show line 3 in the form Stock Option (Right to Buy) +16,700 16,700 D
2024-07-19 Grant or award : show line 4 in the form Stock Option (Right to Buy) +8,350 8,350 D
Loading xslF345X05/form4-07232024_120716.xml…